OpenURL Connection Search

Select item for more details and to access through your institution.

The Diagnostic Industry in a Changing Health Care Environment.
Published in:
Journal of Management Research (09725814), 2015, v. 15, n. 2, p. 91
By:
- Schäfer, H. Hendrik;
- Filser, Ludwig;
- Rohr, Ulrich-P.;
- Messina, Carlo G. M.;
- Laubender, Ruediger P.;
- Dieterle, Thomas;
- Toerien, Eduard;
- Zaugg, Christian E.
Publication type:
Article
Distinct Gene Expression Pattern of Malignant Hematopoietic Stem and Progenitor Cells in Polycythemia Vera.
Published in:
Annals of the New York Academy of Sciences, 2005, v. 1044, n. 1, p. 94, doi. 10.1196/annals.1349.013
By:
- STEIDL, ULRICH;
- SCHROEDER, THOMAS;
- STEIDL, CHRISTIAN;
- KOBBE, GUIDO;
- GRAEF, THORSTEN;
- BORK, SIMONE;
- PECHTEL, SABRINA;
- KLISZEWSKI, SLAWOMIR;
- KUENDGEN, ANDREA;
- ROHR, ULRICH P.;
- FENK, ROLAND;
- SCHROEDER, MICHAEL;
- HAASE, DETLEF;
- HAAS, RAINER;
- KRONENWETT, RALF
Publication type:
Article
Aberrant promoter methylation of p16.
Published in:
International Journal of Cancer, 2005, v. 116, n. 5, p. 720, doi. 10.1002/ijc.21090
By:
- Grote, Hans J.;
- Schmiemann, Viola;
- Geddert, Helene;
- Rohr, Ulrich P.;
- Kappes, Rainer;
- Gabbert, Helmut E.;
- Böcking, Alfred
Publication type:
Article
A decade comparison of regulatory decision patterns for oncology products to all other non‐oncology products among Swissmedic, European Medicines Agency, and US Food and Drug Administration.
Published in:
CTS: Clinical & Translational Science, 2023, v. 16, n. 9, p. 1569, doi. 10.1111/cts.13567
By:
- Rohr, Ulrich‐P.;
- Iovino, Mario;
- Rudofsky, Leonie;
- Li, Qiyu;
- Juritz, Stephanie;
- Gircys, Arunas;
- Wildner, Oliver;
- Bujar, Magda;
- Bolte, Claus;
- Dalla Torre di Sanguinetto, Simon;
- Wolfer, Anita
Publication type:
Article

Found: 4

The Diagnostic Industry in a Changing Health Care Environment.

Distinct Gene Expression Pattern of Malignant Hematopoietic Stem and Progenitor Cells in Polycythemia Vera.

Aberrant promoter methylation of p16.

A decade comparison of regulatory decision patterns for oncology products to all other non‐oncology products among Swissmedic, European Medicines Agency, and US Food and Drug Administration.